As of February 23, 2021, TransEnterix has been renamed Asensus Surgical, Inc.
Along with the name change, the ticker symbol will change to “ASXC” upon the open of trading on Friday, March 5, 2021. Up until that point, the stock will continue to trade under the company name TransEnterix and ticker symbol TRXC.
If you are an existing investor, your ownership will not be impacted. Beginning on March 5, 2021, your holdings will automatically be renamed as Asensus Surgical, ticker symbol ASXC. Up until that point, the stock will continue to show up as TransEnterix and ticker symbol TRXC.
On CTS Letterhead July 19, 1996 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: Registration Statement No. 333-07445 Gentlemen: Pursuant to Rule 477(a) promulgated under the Securities Act of 1933, as amended, Cellular Technology Services Company, Inc. (the "Company") hereby applies for the withdrawal of the above-captioned Registration Statement and all exhibits thereto as the Company has determined to no longer proceed to offer the Common Stock contemplated to be offered by such Registration Statement due to the effect on the Company's share price of the recent volatility in the stock market and the fact that the Company has begun to generate cash from deployment of its Blackbird(R) Platform and Pretect(TM) Anti-Fraud System which the Company anticipates will be sufficient to achieve its growth goals that have been set for 1996. No sales have been made under such Registration Statement. Very truly yours, CELLULAR TECHNICAL SERVICES COMPANY, INC. /s/ Michael E. McConnell Michael E. McConnell Vice President and Chief Financial Officer